drugset / Trial / NCT01214382
Pharmacokinetic Properties of Sertraline Before and After Gastric Bypass Surgery
Phase 3
Completed
31 enrolled
North Dakota State University
National Institutes of Health (NIH) · collab
NaSingle-groupOpen-label
Summary
This study is being conducted to evaluate how the body absorbs and processes the medication sertraline (Zoloft®) before compared to how it is absorbed at two time points after gastric bypass surgery. Participants will be asked to take part in this study at three time points: 1) before their bariatric surgery, 2) at three months following the surgery, and 3) twelve months following surgery. This study will enroll approximately 30 participants.
Timeline
- Start
- 2010-10
- Primary completion
- 2014-08
- Completion
- 2014-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Sertraline | Small molecule | 100 mg | — |
Indications
No indication recorded.